Inhibiting High Mobility Group Box-1 Reduces Early Spinal Cord Edema and Attenuates Astrocyte Activation and Aquaporin-4 Expression after Spinal Cord Injury in Rats
- PMID: 29929431
- DOI: 10.1089/neu.2018.5642
Inhibiting High Mobility Group Box-1 Reduces Early Spinal Cord Edema and Attenuates Astrocyte Activation and Aquaporin-4 Expression after Spinal Cord Injury in Rats
Abstract
High mobility group box-1 (HMGB1) could function as an early trigger for pro-inflammatory activation after spinal cord injury (SCI). Spinal cord edema contributes to inflammatory response mechanisms and a poor clinical prognosis after SCI, for which efficient therapies targeting the specific molecules involved remain limited. This study was designed to evaluate the roles of HMGB1 on the regulation of early spinal cord edema, astrocyte activation, and aquaporin-4 (AQP4) expression in a rat SCI model. Adult female Sprague-Dawley rats underwent laminectomy at T10, and the SCI model was induced by a heavy falling object. After SCI, rats received ethyl pyruvate (EP) or glycyrrhizin (GL) via an intraperitoneal injection to inhibit HMGB1. The effects of HMGB1 inhibition on the early spinal cord edema, astrocyte activation (glial fibrillary acidic protein [GFAP] expression), and AQP4 expression after SCI (12 h-3 days) were analyzed. The results showed that EP or GL effectively inhibited HMGB1 expression in the spinal cord and HMGB1 levels in the serum of SCI rats. HMGB1 inhibition improved motor function, reduced spinal cord water content, and attenuated spinal cord edema in SCI rats. HMGB1 inhibition decreased SCI-associated GFAP and AQP4 overexpression in the spinal cord. Further, HMGB1 inhibition also repressed the activation of the toll-like receptor 4/myeloid differentiation primary response gene 88/nuclear factor-kappa B signaling pathway. These results implicate that HMGB1 inhibition improved locomotor function and reduced early spinal cord edema, which was associated with a downregulation of astrocyte activation (GFAP expression) and AQP4 expression in SCI rats.
Keywords: aquaporin-4; astrocyte; high mobility group box-1; spinal cord edema; spinal cord injury.
Similar articles
-
Astaxanthin ameliorates spinal cord edema and astrocyte activation via suppression of HMGB1/TLR4/NF-κB signaling pathway in a rat model of spinal cord injury.Naunyn Schmiedebergs Arch Pharmacol. 2023 Nov;396(11):3075-3086. doi: 10.1007/s00210-023-02512-7. Epub 2023 May 5. Naunyn Schmiedebergs Arch Pharmacol. 2023. PMID: 37145127
-
Inhibition of HMGB1 Attenuates Spinal Cord Edema by Reducing the Expression of Na+-K+-Cl- Cotransporter-1 and Na+/H+ Exchanger-1 in Both Astrocytes and Endothelial Cells After Spinal Cord Injury in Rats.J Neurotrauma. 2023 Dec;40(23-24):2522-2540. doi: 10.1089/neu.2022.0318. Epub 2023 Apr 18. J Neurotrauma. 2023. PMID: 36815608
-
Inhibition of HMGB1 reduces rat spinal cord astrocytic swelling and AQP4 expression after oxygen-glucose deprivation and reoxygenation via TLR4 and NF-κB signaling in an IL-6-dependent manner.J Neuroinflammation. 2017 Nov 25;14(1):231. doi: 10.1186/s12974-017-1008-1. J Neuroinflammation. 2017. PMID: 29178911 Free PMC article.
-
Aquaporins in spinal cord injury: the janus face of aquaporin 4.Neuroscience. 2010 Jul 28;168(4):1019-35. doi: 10.1016/j.neuroscience.2010.01.037. Epub 2010 Jan 28. Neuroscience. 2010. PMID: 20109536 Free PMC article. Review.
-
The role of aquaporin 4 (AQP4) in spinal cord injury.Biomed Pharmacother. 2022 Jan;145:112384. doi: 10.1016/j.biopha.2021.112384. Epub 2021 Dec 6. Biomed Pharmacother. 2022. PMID: 34915672 Review.
Cited by
-
S100A9 Induces Macrophage M2 Polarization and Immunomodulatory Role in the Lesion Site After Spinal Cord Injury in Rats.Mol Neurobiol. 2024 Jan 11. doi: 10.1007/s12035-024-03920-3. Online ahead of print. Mol Neurobiol. 2024. PMID: 38206470
-
AQP4 is an Emerging Regulator of Pathological Pain: A Narrative Review.Cell Mol Neurobiol. 2023 Nov;43(8):3997-4005. doi: 10.1007/s10571-023-01422-9. Epub 2023 Oct 21. Cell Mol Neurobiol. 2023. PMID: 37864629 Review.
-
Astaxanthin ameliorates spinal cord edema and astrocyte activation via suppression of HMGB1/TLR4/NF-κB signaling pathway in a rat model of spinal cord injury.Naunyn Schmiedebergs Arch Pharmacol. 2023 Nov;396(11):3075-3086. doi: 10.1007/s00210-023-02512-7. Epub 2023 May 5. Naunyn Schmiedebergs Arch Pharmacol. 2023. PMID: 37145127
-
Inhibition of HMGB1 Attenuates Spinal Cord Edema by Reducing the Expression of Na+-K+-Cl- Cotransporter-1 and Na+/H+ Exchanger-1 in Both Astrocytes and Endothelial Cells After Spinal Cord Injury in Rats.J Neurotrauma. 2023 Dec;40(23-24):2522-2540. doi: 10.1089/neu.2022.0318. Epub 2023 Apr 18. J Neurotrauma. 2023. PMID: 36815608
-
Review: The role of HMGB1 in spinal cord injury.Front Immunol. 2023 Jan 12;13:1094925. doi: 10.3389/fimmu.2022.1094925. eCollection 2022. Front Immunol. 2023. PMID: 36713448 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous
